Literature DB >> 6248205

Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells.

D H Ho, C J Carter, N S Brown, J Hester, K McCredie, R S Benjamin, E J Freireich, G P Bodey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6248205

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

1.  Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.

Authors:  J Laliberté; V E Marquez; R L Momparler
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.

Authors:  J A Streifel; S B Howell
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

3.  Modulation of the effect of 1-beta-D-arabinofuranosylcytosine based on changes of cytidine deaminase activity in HL60 cells.

Authors:  J N Mejer; B T Mortensen; I J Christensen
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

4.  Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice.

Authors:  Jan H Beumer; Julie L Eiseman; Robert A Parise; Jeffry A Florian; Erin Joseph; David Z D'Argenio; Robert S Parker; Brittany Kay; Joseph M Covey; Merrill J Egorin
Journal:  Cancer Chemother Pharmacol       Date:  2007-11-15       Impact factor: 3.333

5.  Cytosine arabinoside influx and nucleoside transport sites in acute leukemia.

Authors:  J S Wiley; S P Jones; W H Sawyer; A R Paterson
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.